Literature DB >> 6102474

An assessment of beta-adrenoceptor blockade in man by SK & F 92657, a new drug with combined vasodilator and beta-adrenoceptor blocking actions, and comparison with propranolol [proceedings].

D W Pitcher, P V Curry, J R Trounce.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6102474     DOI: 10.1111/j.1365-2125.1980.tb04858.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  Investigation of a combined arteriolar dilator and beta-adrenoceptor antagonist (SK & F 92657) in the peripheral vessels of man.

Authors:  J G Collier; D W Pitcher
Journal:  Br J Clin Pharmacol       Date:  1980-12       Impact factor: 4.335

2.  Cardiovascular effects in man of intravenous prizidilol hydrochloride (SK&F 92657); a new antihypertensive agent.

Authors:  W M Edmonstone; K K Manghani; A J Bell; M McLeod; G J Milton-Thompson; W L Burland
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

3.  Acute effects of prizidilol on blood pressure, heart rate, catecholamines, renin and aldosterone in essential hypertension.

Authors:  M G Bianchetti; K Boehringer; P Weidmann; L Link; H Schiffl; W H Ziegler
Journal:  Eur J Clin Pharmacol       Date:  1982-10       Impact factor: 2.953

4.  Prizidilol (SK & F 92657), a new vasodilator with beta-blocking properties in the treatment of essential hypertension.

Authors:  T Lüscher; J Havelka; P Greminger; J Tuma; M Täuber; W Siegenthaler; W Vetter
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  Comparison of prizidilol hydrochloride (SK & F 92657), a new antihypertensive agent with beta-adrenoceptor antagonist and vasodilator activity with propranolol and hydralazine in normal volunteers.

Authors:  J A Steiner; A Clancy; K K Manghani; I M James
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.